4P-Pharma is a clinical stage biotech company founded in Lille (France) in 2014. They focus on untreated serious diseases with high unmet medical needs, aiming to rapidly deliver effective, regenerated, first-in-class therapies to patients. Driven by a vision to pair disease biology of unmet pathologies with drug mechanism of action, we aim to evaluate innovative programs with strong scientific rationale, sourced from the top academic research labs and AI tech companies.

Their R&D capabilities within Pasteur Institute at Lille allow us to assess these breakthrough innovations by regenerating active drugs as proprietary first-in-class therapies in the new indication. Once reaching regulatory milestones, we launch single product vehicles (SPVs), in charge of advancing the assets through accelerated clinical development to market approvals and distribution agreements by geographic and therapeutic area. 4P-Pharma is seeking drug repurposing projects with a strong scientific rationale and to build strategic partnership with academic research labs and AI tech companies.